Comparing the Incidence between Tiotropium and ICS/LABA in Real world Use in South Korea (CITRUS study)

Study identification

• EU PAS number:
  EUPAS32329
• Study ID:
  40660
• Official title and acronym:
  Comparing the Incidence between Tiotropium and ICS/LABA in Real world Use in South Korea (CITRUS study)
• DARWIN EU® study:
  No
• Study countries:
  Korea, Republic of
• Study description:
  Non-interventional study to compare effectiveness of LAMA to fixed dose combination of inhaled corticosteroid and long-acting beta agonists (ICS/LABA) in patients with chronic obstructive pulmonary disease (COPD) based on existing data
• Study status:
  Ongoing

Research institutions and networks

Institutions

Soeun Lee

Study timelines

Date when funding contract was signed

Planned:20/12/2019

Actual:08/06/2020

Study start date

Planned:24/12/2019

Actual:03/03/2020

Data analysis start date

Planned:07/01/2020

Actual:06/04/2021

Date of interim report, if expected

Planned:02/06/2020

Date of final study report

Planned:30/06/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer-ingelheim

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable